Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Evaluation of liver failure in a pediatric transplant recipient of a liver allograft with inherited chromosomally integrated HHV-6B.

Bonnafous P, Phan TL, Himes R, Eldin K, Gautheret-Dejean A, Prusty BK, Agut H, Munoz FM.

J Med Virol. 2020 Feb;92(2):241-250. doi: 10.1002/jmv.25600. Epub 2019 Oct 20.

PMID:
31579937
2.

Phenotypic and Functional Differences between Human Herpesvirus 6- and Human Cytomegalovirus-Specific T Cells.

Fastenackels S, Bayard C, Larsen M, Magnier P, Bonnafous P, Seddiki N, Appay V, Gautheret-Dejean A, Sauce D.

J Virol. 2019 Jun 14;93(13). pii: e02321-18. doi: 10.1128/JVI.02321-18. Print 2019 Jul 1.

3.

Need for a better characterization of HHV-6 infections and associated clinical impacts.

Bonnafous P, Marlet J, Gaudy-Graffin C, Gautheret-Dejean A.

Am J Transplant. 2019 Jan;19(1):304-305. doi: 10.1111/ajt.15013. Epub 2018 Aug 1. No abstract available.

4.

Fatal outcome after reactivation of inherited chromosomally integrated HHV-6A (iciHHV-6A) transmitted through liver transplantation.

Bonnafous P, Marlet J, Bouvet D, Salamé E, Tellier AC, Guyetant S, Goudeau A, Agut H, Gautheret-Dejean A, Gaudy-Graffin C.

Am J Transplant. 2018 Jun;18(6):1548-1551. doi: 10.1111/ajt.14657. Epub 2018 Jan 27.

5.

[Latest news on the inherited chromosomally integrated form of human herpesvirus-6 (iciHHV-6)].

Gautheret-Dejean A.

Med Sci (Paris). 2017 Aug-Sep;33(8-9):730-731. doi: 10.1051/medsci/20173308014. Epub 2017 Sep 18. French. No abstract available.

6.

Human Herpesvirus 6 (HHV-6) necrotizing encephalitis, a rare condition in immunocompromised patients: The importance of brain biopsy associated with HHV-6 testing.

Le Guennec L, Mokhtari K, Chauvet D, Dupuis N, Roos-Weil D, Agut H, Leclercq D, Psimaras D, Mayaux J, Demeret S, Choquet S, Auvin S, Bonnafous P, Gautheret-Dejean A, Weiss N.

J Neurol Sci. 2017 Jun 15;377:112-115. doi: 10.1016/j.jns.2017.04.003. Epub 2017 Apr 6. No abstract available.

PMID:
28477677
7.

Vaginal Neoplasia Induced by an Unusual Papillomavirus Subtype in a Woman with Inherited Chromosomally Integrated Human Herpesvirus Type 6A.

Pichon M, Gaymard A, Lebail-Carval K, Frobert E, Beaufils E, Chene G, Tommasino M, Lina B, Gaucherand P, Gautheret-Dejean A, Bonnafous P, Gheit T, Buenerd A, Lamblin G, Mekki Y.

Gynecol Obstet Invest. 2017;82(3):307-310. doi: 10.1159/000470907. Epub 2017 Apr 6.

PMID:
28380476
8.

Cytokine and cellular responses to human herpesvirus-6B in patients with B-acute lymphoblastic leukemia.

Nefzi F, Lambert C, Gautheret-Dejean A, Fisson S, Khebizi Q, Khelif A, Agut H, Aouni M.

Microbiol Immunol. 2016 Nov;60(11):770-777. doi: 10.1111/1348-0421.12452.

9.

Update on infections with human herpesviruses 6A, 6B, and 7.

Agut H, Bonnafous P, Gautheret-Dejean A.

Med Mal Infect. 2017 Mar;47(2):83-91. doi: 10.1016/j.medmal.2016.09.004. Epub 2016 Oct 20. Review.

PMID:
27773488
10.

Human Herpesviruses 6A, 6B, and 7.

Agut H, Bonnafous P, Gautheret-Dejean A.

Microbiol Spectr. 2016 Jun;4(3). doi: 10.1128/microbiolspec.DMIH2-0007-2015. Review.

PMID:
27337451
11.

[Diagnosis and practice of virological monitoring of infections by the human herpesviruses 6A and 6B].

Gautheret-Dejean A, Bonnafous P, Agut H.

Ann Biol Clin (Paris). 2016 Mar-Apr;74(2):156-67. doi: 10.1684/abc.2016.1122. Review. French.

12.

Response to Hønge et al.: Comment on Gautheret-Dejean et al.: Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infections.

Gautheret-Dejean A, Bocobza J, Brunet S, Damond F, Plantier JC, Barin F.

J Med Virol. 2016 Mar;88(3):369-70. doi: 10.1002/jmv.24390. Epub 2015 Oct 5. No abstract available.

PMID:
26399874
13.

Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infections.

Gautheret-Dejean A, Bocobza J, Brunet S, Damond F, Plantier JC, Barin F.

J Med Virol. 2015 Dec;87(12):2061-6. doi: 10.1002/jmv.24282. Epub 2015 Jun 16.

PMID:
26081750
14.

Laboratory and clinical aspects of human herpesvirus 6 infections.

Agut H, Bonnafous P, Gautheret-Dejean A.

Clin Microbiol Rev. 2015 Apr;28(2):313-35. doi: 10.1128/CMR.00122-14. Review.

15.

Very early ART resulting in the absence of HIV-1 antibodies and in a sustained undetectable plasma HIV-1-RNA and proviral-DNA in an HLA-B*5701 and Δ32 heterozygote HIV-1-infected patient was not associated with functional cure.

Calin R, Fourati S, Schneider L, Gautheret-Dejean A, Lambert-Niclot S, Wirden M, Carcelain G, Katlama C, Marcelin AG, Tubiana R.

J Antimicrob Chemother. 2015 Jan;70(1):317-9. doi: 10.1093/jac/dku370. Epub 2014 Sep 19. No abstract available.

PMID:
25239464
16.

Quantitative analysis of human herpesvirus-6 and human cytomegalovirus in blood and saliva from patients with acute leukemia.

Nefzi F, Ben Salem NA, Khelif A, Feki S, Aouni M, Gautheret-Dejean A.

J Med Virol. 2015 Mar;87(3):451-60. doi: 10.1002/jmv.24059. Epub 2014 Aug 27.

PMID:
25163462
17.

Prevalence of herpesviruses at onset of idiopathic nephrotic syndrome.

Dossier C, Sellier-Leclerc AL, Rousseau A, Michel Y, Gautheret-Dejean A, Englender M, Madhi F, Charbit M, Ulinski T, Simon T, Jacqz-Aigrain E, Deschênes G.

Pediatr Nephrol. 2014 Dec;29(12):2325-31. doi: 10.1007/s00467-014-2860-1. Epub 2014 Jun 5.

PMID:
24899237
18.

Presence of HHV-6 genome in spermatozoa in a context of couples with low fertility: what type of infection?

Godet AN, Soignon G, Koubi H, Bonnafous P, Agut H, Poirot C, Gautheret-Dejean A.

Andrologia. 2015 Jun;47(5):531-5. doi: 10.1111/and.12299. Epub 2014 May 20.

PMID:
24846813
19.

[An atypical presentation of Kikuchi-Fujimoto disease].

Méni C, Chabrol A, Wassef M, Gautheret-Dejean A, Bergmann JF, Mouly S.

Rev Med Interne. 2013 Jun;34(6):373-6. doi: 10.1016/j.revmed.2012.11.002. Epub 2012 Nov 29. French.

PMID:
23200797
20.

Twelve months of routine HIV screening in 6 emergency departments in the Paris area: results from the ANRS URDEP study.

Casalino E, Bernot B, Bouchaud O, Alloui C, Choquet C, Bouvet E, Damond F, Firmin S, Delobelle A, Nkoumazok BE, Der Sahakian G, Viard JP, Zbar OZ, Aslangul E, Krivine A, Zundel J, Ghosn J, Nordmann P, Claessens YE, Tahi T, Riou B, Gautheret-Dejean A, Katlama C, Hausfater P, Brun-Vézinet F, Costagliola D.

PLoS One. 2012;7(10):e46437. doi: 10.1371/journal.pone.0046437. Epub 2012 Oct 2.

21.

Confirmation of the low clinical effect of human herpesvirus-6 and -7 infections after renal transplantation.

Caïola D, Karras A, Flandre P, Boutolleau D, Scieux C, Agut H, Legendre C, Gautheret-Dejean A.

J Med Virol. 2012 Mar;84(3):450-6. doi: 10.1002/jmv.23206.

PMID:
22246831
22.

Quantitation of human herpesvirus-6A, -6B and -7 DNAs in whole blood, mononuclear and polymorphonuclear cell fractions from healthy blood donors.

Géraudie B, Charrier M, Bonnafous P, Heurté D, Desmonet M, Bartoletti MA, Penasse C, Agut H, Gautheret-Dejean A.

J Clin Virol. 2012 Feb;53(2):151-5. doi: 10.1016/j.jcv.2011.10.017. Epub 2011 Nov 30.

PMID:
22133730
23.

Chromosomally integrated human herpesvirus 6: questions and answers.

Pellett PE, Ablashi DV, Ambros PF, Agut H, Caserta MT, Descamps V, Flamand L, Gautheret-Dejean A, Hall CB, Kamble RT, Kuehl U, Lassner D, Lautenschlager I, Loomis KS, Luppi M, Lusso P, Medveczky PG, Montoya JG, Mori Y, Ogata M, Pritchett JC, Rogez S, Seto E, Ward KN, Yoshikawa T, Razonable RR.

Rev Med Virol. 2012 May;22(3):144-55. doi: 10.1002/rmv.715. Epub 2011 Nov 4. Review.

24.

Conservation of HHV-6 DNA polymerase processivity factor sequence and predicted structure suggests it as a target for antiviral development.

Bonnafous P, Verbelen M, Petrella S, Deback C, Gautheret-Dejean A, Boutolleau D, Naesens L, Agut H.

Antiviral Res. 2010 Jun;86(3):316-9. doi: 10.1016/j.antiviral.2010.03.005. Epub 2010 Mar 16.

PMID:
20298721
25.

Testing the susceptibility of human herpesviruses to antivirals.

Agut H, Boutolleau D, Deback C, Bonnafous P, Gautheret-Dejean A.

Future Microbiol. 2009 Nov;4(9):1111-23. doi: 10.2217/fmb.09.83. Review.

PMID:
19895215
26.

[Evaluation of the LightCycler 480 real-time PCR system for the measurement of CMV, EBV, HHV-6 and BKV viral loads in whole blood].

Boutolleau D, Deback C, Géli J, Aït-Arkoub Z, Angleraud F, Gautheret-Dejean A, Agut H.

Pathol Biol (Paris). 2010 Apr;58(2):166-9. doi: 10.1016/j.patbio.2009.06.006. Epub 2009 Nov 4. French.

PMID:
19892483
27.

Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections.

Plantier JC, Djemai M, Lemée V, Reggiani A, Leoz M, Burc L, Vessière A, Rousset D, Poveda JD, Henquell C, Gautheret-Dejean A, Barin F.

J Clin Microbiol. 2009 Sep;47(9):2906-11. doi: 10.1128/JCM.00602-09. Epub 2009 Jul 22.

28.

Prevalence of human herpesvirus-6 chromosomal integration (CIHHV-6) in Italian solid organ and allogeneic stem cell transplant patients.

Potenza L, Barozzi P, Masetti M, Pecorari M, Bresciani P, Gautheret-Dejean A, Riva G, Vallerini D, Tagliazucchi S, Codeluppi M, Di Benedetto F, Gerunda GE, Narni F, Torelli G, Luppi M.

Am J Transplant. 2009 Jul;9(7):1690-7. doi: 10.1111/j.1600-6143.2009.02685.x. Epub 2009 Jun 10.

29.

Different expression of human herpesvirus-6 (HHV-6) load in whole blood may have a significant impact on the diagnosis of active infection.

Gautheret-Dejean A, Henquell C, Mousnier F, Boutolleau D, Bonnafous P, Dhédin N, Settegrana C, Agut H.

J Clin Virol. 2009 Sep;46(1):33-6. doi: 10.1016/j.jcv.2009.05.020. Epub 2009 Jun 7.

PMID:
19505844
30.

Use of the Roche LightCycler 480 system in a routine laboratory setting for molecular diagnosis of opportunistic viral infections: Evaluation on whole blood specimens and proficiency panels.

Deback C, Géli J, Aït-Arkoub Z, Angleraud F, Gautheret-Dejean A, Agut H, Boutolleau D.

J Virol Methods. 2009 Aug;159(2):291-4. doi: 10.1016/j.jviromet.2009.03.027. Epub 2009 Apr 9.

PMID:
19490982
31.

Length variability of telomeric repeat sequences of human herpesvirus 6 DNA.

Achour A, Malet I, Deback C, Bonnafous P, Boutolleau D, Gautheret-Dejean A, Agut H.

J Virol Methods. 2009 Jul;159(1):127-30. doi: 10.1016/j.jviromet.2009.03.002. Epub 2009 Mar 14.

PMID:
19442857
32.

Contribution of human herpesvirus 6 (HHV-6) viral load in whole blood and serum to investigate integrated HHV-6 transmission after haematopoietic stem cell transplantation.

Jeulin H, Salmon A, Gautheret-Dejean A, Agut H, Bordigoni P, Fortier B, Venard V.

J Clin Virol. 2009 May;45(1):43-6. doi: 10.1016/j.jcv.2009.02.006. Epub 2009 Mar 24.

PMID:
19321385
33.

Utilization of microsatellite polymorphism for differentiating herpes simplex virus type 1 strains.

Deback C, Boutolleau D, Depienne C, Luyt CE, Bonnafous P, Gautheret-Dejean A, Garrigue I, Agut H.

J Clin Microbiol. 2009 Mar;47(3):533-40. doi: 10.1128/JCM.01565-08. Epub 2008 Dec 24.

34.

Unequal detection of HIV type 1 group O infection by simple rapid tests.

Gautheret-Dejean A, Mesmin-Poho S, Birguel J, Lemée V, Huraux JM, Plantier JC.

Clin Infect Dis. 2008 Jun 15;46(12):1936-7. doi: 10.1086/588561. No abstract available.

PMID:
18540814
35.

Variability of gB and gH genes of human herpesvirus-6 among clinical specimens.

Achour A, Malet I, Le Gal F, Dehée A, Gautheret-Dejean A, Bonnafous P, Agut H.

J Med Virol. 2008 Jul;80(7):1211-21. doi: 10.1002/jmv.21205.

PMID:
18461623
36.

Human herpesvirus-6 infection: a prospective study evaluating HHV-6 DNA levels in liver from children with acute liver failure.

Chevret L, Boutolleau D, Halimi-Idri N, Branchereau S, Baujard C, Fabre M, Gautheret-Dejean A, Debray D.

J Med Virol. 2008 Jun;80(6):1051-7. doi: 10.1002/jmv.21143.

PMID:
18428148
37.

Detection of human herpesviruses HHV-6, HHV-7 and HHV-8 in whole blood by real-time PCR using the new CMV, HHV-6, 7, 8 R-gene kit.

Deback C, Agbalika F, Scieux C, Marcelin AG, Gautheret-Dejean A, Cherot J, Hermet L, Roger O, Agut H.

J Virol Methods. 2008 May;149(2):285-91. doi: 10.1016/j.jviromet.2008.01.026. Epub 2008 Mar 10.

PMID:
18329730
38.

Quantitation of Human herpes virus 6 genome in children with acute lymphoblastic leukemia.

Seror E, Coquerel B, Gautheret-Dejean A, Ballerini P, Landman-Parker J, Leverger G, Schneider P, Vannier JP.

J Med Virol. 2008 Apr;80(4):689-93. doi: 10.1002/jmv.21118.

PMID:
18297709
39.

Characterization of a cidofovir-resistant HHV-6 mutant obtained by in vitro selection.

Bonnafous P, Boutolleau D, Naesens L, Deback C, Gautheret-Dejean A, Agut H.

Antiviral Res. 2008 Mar;77(3):237-40. doi: 10.1016/j.antiviral.2007.12.004. Epub 2008 Jan 7.

PMID:
18241936
40.

Different mutations in the HHV-6 DNA polymerase gene accounting for resistance to foscarnet.

Bonnafous P, Naesens L, Petrella S, Gautheret-Dejean A, Boutolleau D, Sougakoff W, Agut H.

Antivir Ther. 2007;12(6):877-88.

PMID:
17926642
41.

Human herpesvirus-6 (HHV-6) DNA in plasma reflects the presence of infected blood cells rather than circulating viral particles.

Achour A, Boutolleau D, Slim A, Agut H, Gautheret-Dejean A.

J Clin Virol. 2007 Apr;38(4):280-5. Epub 2007 Mar 6.

PMID:
17339132
42.

Is human herpesvirus-6 DNA in plasma the right marker for active infection?

Achour A, Boutolleau D, Gautheret-Dejean A, Agut H.

J Infect Dis. 2006 Dec 15;194(12):1795-6; author reply 1796-7. Review. No abstract available.

PMID:
17109358
43.

Human herpesvirus 6 genome integration: a possible cause of misdiagnosis of active viral infection?

Boutolleau D, Agut H, Gautheret-Dejean A.

J Infect Dis. 2006 Oct 1;194(7):1019-20; author reply 1021-3. No abstract available.

PMID:
16960791
44.

Polymorphonuclear leukocytes mainly contribute to human herpesvirus-6 load in the peripheral blood of patients.

Palleau S, Boutolleau D, Bonnafous P, Agut H, Gautheret-Dejean A.

Clin Infect Dis. 2006 May 1;42(9):1342-3. No abstract available.

PMID:
16586395
45.

Fatal HHV-6 associated encephalitis in an HIV-1 infected patient treated with cidofovir.

Astriti M, Zeller V, Boutolleau D, Gautheret-Dejean A, Allen G, Seilhean D, Agut H, Bricaire F, Katlama C, Bossi P.

J Infect. 2006 Apr;52(4):237-42. Epub 2005 Sep 26.

PMID:
16188320
46.

Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology.

Boutolleau D, Duros C, Bonnafous P, Caïola D, Karras A, Castro ND, Ouachée M, Narcy P, Gueudin M, Agut H, Gautheret-Dejean A.

J Clin Virol. 2006 Mar;35(3):257-63. Epub 2005 Sep 23.

PMID:
16183328
47.

Detection of human herpesvirus 7 DNA in peripheral blood reflects mainly CD4+ cell count in patients infected with HIV.

Boutolleau D, Bonduelle O, Sabard A, Devers L, Agut H, Gautheret-Dejean A; French ATL Study Group.

J Med Virol. 2005 Jun;76(2):223-8.

PMID:
15834866
48.

Persistence of DNA in cell cultures may jeopardize the analysis of human herpesvirus 6 dynamics by means of real-time PCR.

Bonnafous P, Gautheret-Dejean A, Boutolleau D, Caïola D, Agut H.

J Virol Methods. 2005 Apr;125(1):95-8. Epub 2005 Jan 28.

PMID:
15737421
49.

Is human herpesvirus-7 a marker or a competitor for HIV progression?

Boutolleau D, Bonduelle O, Agut H, Gautheret-Dejean A; French ALT Study Group.

AIDS. 2004 Jan 23;18(2):358-9. No abstract available.

PMID:
15075568
50.

Real-time PCR as a versatile tool for investigating the susceptibility of human herpesvirus 6 to antiviral agents.

Macé M, Manichanh C, Bonnafous P, Précigout S, Boutolleau D, Gautheret-Dejean A, Agut H.

Antimicrob Agents Chemother. 2003 Sep;47(9):3021-4.

Supplemental Content

Loading ...
Support Center